MedTrace Logo

Impact of Metformin on In Vitro Fertilization Outcomes in Overweight and Obese PCOS Women

NCT02910817 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2017-11-14

No results posted yet for this study

Summary

RCT to investigate whether metformin co-treatment would improve IVF outcomes in overweight and obese women with PCOS.

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

Metformin

The metformin-treated group received metformin (1000 mg per day) with the start of controlled ovarian stimulation (COH) until the day of the pregnancy check.

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Osama Abdalmageed · Women health center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02910817 on ClinicalTrials.gov